Subcutaneous Injections Often considered for achieving more targeted and systemic effects, subcutaneous injections deliver GHK-Cu directly into the body, allowing for higher bioavailability and more predictable concentrations
What community members commonly report: Injection-site reactions (redness, swelling) expected with large-volume subcutaneous injections Mild flu-like symptoms in the 24-72 hours following injection, which some interpret as an immune response to senescent cell die-off Fatigue and general malaise lasting 1-3 days post-injection No noticeable positive effects yet What community members probably will NOT notice: Improved energy or vitality Visible changes in skin, hair, or physical appearance Measurable changes in bloodwork Any performance enhancement Realistic expectation: Week 1 is about initiating the senolytic process
Conversely, decreased Cav-1 level or obstructed Cav-1 and eNOS interaction can release eNOS favoring its activation and induction of nitric oxide production that is known for its protective effect on vessels 44,45
1 % works well for sensitive or beginner skin
The two share the same three peptides at identical doses when inflammation is not a key issue to resolve, KLOW can be switched out for GLOW without regression during a 12-week protocol